Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

Examining the role of the JAK-STAT pathway in ICI-arthritis and the effects of JAK inhibition on ICI in a novel tumor model of ICI-arthritis

FY 2025-26

Summary
Cancer is a leading cause of death in the world and immune checkpoint inhibitors (ICIs) have emerged as highly effective therapies. Almost half of cancer patients are eligible to receive ICI. Unfortunately, ICIs often have toxic side effects, including debilitating arthritis that can significantly affect a patient's quality of life. So-called ICI-arthritis is usually treated with drugs that suppress the immune system. However, there is concern that these treatments can lead to cancer progression by negatively impacting the anti-cancer effects of ICIs. We have developed a mouse model to study ICI-arthritis and we will use this model to study the interactions of arthritis treatments with ICIs to provide information on the safety of these combinations. Using samples from ICI-arthritis patients, we also will attempt to deepen our knowledge of the mechanism leading to the development of ICI-arthritis. Understanding the mechanisms of ICI-arthritis is crucial in identifying the most effective therapies to target this novel disease. This work could help with evidence-based clinical practice.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
560220
Name
Papadopoulos Theodoros
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Examining the role of the JAK-STAT pathway in ICI-arthritis and the effects of JAK inhibition on ICI in a novel tumor model of ICI-arthritis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cancer; Cancer And Ici-Arthritis Mouse Modelling; Flow Cytometry; Immune Checkpoint Inhibitor-Arthritis; Immune Checkpoint Inhibitors; Immune Related Adverse Events; Jak-Stat; Proteomics - Somascan; Single Cell Rna Sequencing; Tofacitinib
Abstract
Cancer is a leading cause of death in the world and immune checkpoint inhibitors (ICIs) have emerged as highly effective therapies. Almost half of cancer patients are eligible to receive ICI. Unfortunately, ICIs often have toxic side effects, including debilitating arthritis that can significantly affect a patient's quality of life. So-called ICI-arthritis is usually treated with drugs that suppress the immune system. However, there is concern that these treatments can lead to cancer progression by negatively impacting the anti-cancer effects of ICIs. We have developed a mouse model to study ICI-arthritis and we will use this model to study the interactions of arthritis treatments with ICIs to provide information on the safety of these combinations. Using samples from ICI-arthritis patients, we also will attempt to deepen our knowledge of the mechanism leading to the development of ICI-arthritis. Understanding the mechanisms of ICI-arthritis is crucial in identifying the most effective therapies to target this novel disease. This work could help with evidence-based clinical practice.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Papadopoulos, Theodoros
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
McGill University - $120,000 Grant (2025-26) | Canada Spends